Health status instrument vs. prognostic instrument for assessing chronic obstructive pulmonary disease in clinical practice

International Journal of Clinical Practice

Volumn 64, Issue 11, 2010, Pages 1465-1466

  Louis, R ^a   Corhay, J L ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BODY MASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONSENSUS; COUGHING; DISEASE ASSOCIATION; DYSPNEA; EDITORIAL; EMPHYSEMA; EXERCISE; FATIGUE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; INSTRUMENT; LUNG FUNCTION; LUNG TRANSPLANTATION; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MORTALITY; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REHABILITATION CARE; RESPIRATORY AIRFLOW; SLEEP; SOCIAL STATUS; SPIROMETRY; TREATMENT INDICATION; WHEEZING;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 77956810316     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02475.x     Document Type: Editorial

References (14)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004 364 : 613 20.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBIWHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop . Am J Respir Crit Care Med 2001 163 : 1256 76.
3. Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007 370 : 741 50.
4. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007 370 : 797 9.
5. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000 71 : 733 8.
6. Nici L, Donner C, Wouters E et al. American Thoracic SocietyEuropean Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006 173 : 1390 413.
7. Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006 27 : 822 32.
8. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 350 : 1005 12.
9. Van de Bemt L, Schermer T. Multicomponent staging indices for COPD in daily patient care: what's the yield? Int J Clin Pract 2010 64 : 1475 9.
10. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009 18 : 208 15.
11. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J 2009 34 : 648 54.
12. Jones RC, Donaldson GC, Chavannes NH et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009 180 : 1189 95.
13. Puhan MA, Garcia-Aymerich J, Frey M et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009 374 : 704 11.
14. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a of the ATSERS position paper. Eur Respir J 2004 23 : 932 46.